← board
TRAX
distress 3/10 · well-funded / low risk$37.01-3%today-3% from 52w high
Revenue
pre-revenue
Liquidity
$248M
Runway
1.9 yrs
Shares 1y
—
Price & events
+94.8% over 6M
CatalystRating changeDilutionFinancingdashed = today
-3.0%
1D
+2.2%
1W
+108.2%
1M
+94.8%
3M
—
6M
—
1Y
—
2Y
—
5Y
+94.8%
All
Overview
- Market Cap
- $1.29B
- Volume
- 22.03K
- 52 Week Range
- $15.32 – $38.17
- Total Shares
- 34.89M
- Float Shares
- 31.05M
- % Held by Insiders
- 6.60%
- % Held by Institutions
- 50.79%
- RVOL
- 0.03x
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-07earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
strong buy · target $43 (+16% upside) · 8 analysts
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-22FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot
- 2026-07-17First Tracks Biotherapeutics Inc. (TRAX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
- 2026-07-10TRAX Stock Surges As Traders Pile Into Biotech Momentum - timothysykes.com
- 2026-07-10TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart - mexc.co
- 2026-07-10Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLT - RTTNews
- 2026-07-10TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Yahoo Finance
- 2026-07-10XPEV Stock Rises 1.5% As CEO Takes First Robotaxi Ride In Guangzhou - Stocktwits
- 2026-07-10TRAX Stock Hits All-Time High — What's Driving The Super Rally? - Stocktwits
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.